高密度脂蛋白位于NLRP3炎症酶和心肌梗塞之间的界面
Helison R P Carmo1, Isabella Bonilha1, Joaquim Barreto1
1Atherosclerosis and Vascular Biology Laboratory (Aterolab), Division of Cardiology, State University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil.
International journal of molecular sciences
|January 27, 2024
概括
高密度脂蛋白 (HDL) 可以通过调节NLRP3炎症酶激活来减轻心肌梗塞 (MI) 损伤,这是再注射后细胞死亡的关键驱动因素. 这篇评论探讨了HDL.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 细胞死亡机制 细胞死亡机制
背景情况:
- 心肌梗塞 (MI) 继续导致高发病率和死亡率,与反损伤有关.
- 重灌会触发有害的细胞事件,包括氧化应激,炎症和像热死这样的编程细胞死亡途径.
- 热症由NLRP3炎症酶介导,这是一个关键的炎症综合体.
研究的目的:
- 审查炎症酶激活在心肌梗塞中的作用.
- 分析高密度脂蛋白 (HDL) 如何调节MI后的NLRP3炎症酶激活.
主要方法:
- 关于在心肌梗塞中炎症酶激活和HDL功能的综合文献综述.
- 对HDL成分与NLRP3炎症体信号之间的相互作用现有研究的分析.
主要成果:
- NLRP3炎症酶激活是肌肉心脏损伤和转流后细胞死亡的重要因素.
- 高密度脂蛋白 (HDL) 具有可以促进或抑制NLRP3炎症酶激活的成分.
结论:
- 准NLRP3炎症酶激活是一种潜在的治疗策略,可以减少与心脏病相关的损伤.
- 高脂对NLRP3炎症酶的调节作用需要进一步研究新型心脏病治疗的发展.
更多相关视频
06:52Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
10.7K
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.3K
相关概念视频
01:38Inflammation
53.4K
Overview
53.4K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
92
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92